Pepric appoints Dr. Enrico Bastianelli as independent Director

01-Jun-2015 - Belgium

The General Assembly of Pepric appointed Dr. Enrico Bastianelli as independent non-executive Board member. Dr. Bastianelli is the CEO of Bone Therapeutics since 2006, a cell therapy company for bone fracture repair and prevention. Previously, Dr. Bastianelli gained a tremendous expertise in the cell and pharmaceutical industry based on many years of experience at Procter and Gamble Pharmaceuticals, McKinsey & Co and ProSkelia.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances